Dyslipidemia is a major modifiable cardiovascular disease (CVD) risk factor encompassing elevations in total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG), and low levels of high-density lipoprotein cholesterol (HDL-C). In addition, novel lipid and lipoprotein markers such as lipoprotein particle size and number, apolipoproteins, and TG-rich lipoproteins are emerging as risk factors that contribute to CVD risk. The National Cholesterol Education Program Adult Treatment Panel III has put forth widely recognized guidelines establishing lipid and lipoprotein modification goals for both primary and secondary prevention. Yet data from the National Health and Nutrition Examination Survey indicate that many adults have not achieved target levels for all lipids and lipoproteins. Therefore, critical evaluation of the current strategies for dyslipidemia management is needed to strengthen management ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles